New Delhi [India], June 9 (ANI): Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial will publish the data in July following that the company will be applying for the full licensure of COVAXIN.
New Delhi [India], June 9 (ANI): The Central Industrial Security Force will take over security of the Hyderabad campus of Bharat Biotech, one of the major COVID-19 vaccine manufacturers in the country, informed CISF on Tuesday.
New Delhi [India], June 8 (ANI): As part of the revised COVID-19 vaccine policy, the Centre on Tuesday issued an order capping the prices for administration of three approved coronavirus vaccines in private hospitals across the country.
New Delhi [India], June 8 (ANI): The Union Health Ministry on Tuesday informed that the Centre has placed an order to purchase 25 crores doses of Covishield and 19 crore doses of Covaxin.
New Delhi [India], June 7 (ANI): The Delhi government on Monday informed the Delhi High Court that it has directed that all private hospitals and nursing homes functioning as COVID vaccination centres to ensure that the Covaxin will be used to vaccinate only those people (of age group 18-
New Delhi [India], June 7 (ANI): Covishield vaccine produced more antibodies than Covaxin, according to a preliminary study by Coronavirus Vaccine-induced Antibody Titre (COVAT) involving healthcare workers (HCW) who have received both doses of either of the two vaccines.
New Delhi [India], June 6 (ANI): The All India Institute of Medical Sciences (AIIMS), Delhi, will start screening children for clinical trials of indigenous home-grown COVID-19 vaccine, Bharat Biotech's Covaxin, from Monday, sources said.
New Delhi [India], June 6 (ANI): The Delhi government on Sunday ordered all private hospitals and nursing homes, functioning as COVID vaccination centres for Covaxin, to ensure that the doses are used only to vaccinate those people from 18-44 age group who are eligible for receiving the s
Hyderabad [Telangana] , June 5 (ANI): Brazil has approved the import of Bharat Biotech manufactured COVID-19 vaccine Covaxin into the country with regulations, informed ANVISA on Friday.
Washington [US], June 5 (ANI): US has so far contributed USD 2 billion to GAVI for COVAX facility, a global risk-sharing mechanism for pooled procurement and equitable distribution of COVID-19 vaccines.
New Delhi [India], June 4 (ANI): Delhi government on Friday told the Delhi High Court that Bharat Biotech supplied only 1.5 lakh doses of COVID-19 vaccine 'Covaxin' in May against a promise of five lakh doses.
Washington DC [US], June 4 (ANI): A 'substantial number' of vaccine doses will go to India under the US strategy for global vaccine sharing program, said Gayle E Smith, the US State Department Coordinator for COVID-19 Response and Health Security on Friday.